Demonstrating cardiovascular (CV) benefits with lipid-lowering therapy (LLT) requires long-term randomized clinical trials (RCTs) with thousands of patients. Innovative approaches such as in silico ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results